Meditech Formula 1 Injection Recalled Due to Expired Active Ingredient
Meditech Laboratories is recalling 1,320 vials of Formula 1 Injection because the active ingredient expired before the labeled Beyond Use Date.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a stability issue with an expired active ingredient without reported injuries or illnesses, fitting the criteria for a moderate severity rating.
Plain-English summary
Meditech Laboratories, Inc. is recalling 1,320 vials of Formula 1 Injection, a prescription medication containing papaverine, phentolamine, atropine, and PGE. The recall is due to a stability issue where the product was manufactured with an active ingredient that expired before the labeled Beyond Use Date.
The affected lots are 011916-1 (Expiration 04/19/16) and 020316-1 (Expiration 05/03/16). The product was distributed nationwide.
Consumers and healthcare providers should stop using the recalled product and contact Meditech Laboratories for further instructions.
The recalled product
- Product
- Formula 1 (Papaverine 1.8 mg, Phentolamine 0.2 mg, Atropine 0.02 mg, PGE 18 mcg/mL) Injection, 5 mL vial, Rx only, Meditech Laboratories, Inc., 3200 Polaris Ave., Suite 27, Las Vegas, NV 89102.
- Manufacturer
- Meditech Laboratories, Inc
- Category
- Drug — Injection
- Affected units
- 1,320
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot#: 011916-1
- Exp 04/19/16
- 020316-1
- Exp 05/03/16
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 7 recalled by Meditech Laboratories, Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 7 products in this recall →Related recalls
Same manufacturer · Meditech Laboratories, Inc
See all →- SevereMeditech Formula 9 Injection Recalled for Sterility Assurance Issues
FDA (Drugs) · 2016-04-13
- SevereMeditech Formula 0 Injection Recalled for Sterility Assurance Issues
FDA (Drugs) · 2016-04-13
- SevereMeditech Formula 4 Injection Recalled for Sterility Assurance Issues
FDA (Drugs) · 2016-04-13
- ModerateMeditech Formula 3 Injection Recalled Due to Expired Active Ingredient
FDA (Drugs) · 2016-04-13
- SevereMeditech Formula 2 Injection Recalled for Superpotent Drug Ingredient
FDA (Drugs) · 2016-04-13
Same hazard · stability
See all →- ModeratePhilips DigitalDiagnost C90 delivered without required wall stand seismic kit
FDA (Devices) · 2026-06-17
- ModerateAlbuterol inhalers recalled after failing stability specification for particle size distribution
FDA (Drugs) · 2025-08-27
- ModerateHemoCue glucose microcuvettes experienced transit time outside of specified limits
FDA (Devices) · 2025-07-09
- ModerateApollo Care Recalls Vancomycin IV Bags Due to Unsupported Expiry Date
FDA (Drugs) · 2018-04-04
- SevereApollo Care Recalls Vancomycin IV Bags Due to Unsupported Expiry Date
FDA (Drugs) · 2018-03-14